The German Center for Lung Research (DZL) was honored with the Balzan Prize for exceptional achievements on November 15th in Bern. The prize is worth 750 000 Swiss Francs.
In collaboration with an international team, DZL scientists from Research Center Borstel developed and tested a new antibody which might be used against inflammatory diseases. The results of this study were published in Nature Immunology.
Is computed tomography suitable for detecting lung cancer at a very early stage and thus still well treatable? Scientists at the German Cancer Research Center have investigated this with the LUSI study started in 2007.
Although research is advancing with great strides, the life expectancy of people with cystic fibrosis (CF) is still significantly reduced. The genetic disorder causes severe infections of the lungs associated with the increasing accumulation of mucus clogging the airways.
Prematurely born infants often develop a chronic lung disease known as Bronchopulmonary Dysplasia (BPD). To date, it has only been possible to diagnose the condition based on clinical symptoms and with little differentiation.
The German Center for Lung Research (DZL) is an association of the leading university and non-university institutions dedicated to lung research in Germany. Using translational research methods, the DZL seeks to jointly develop new approaches for the prevention, diagnosis and therapy of serious lung diseases including asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, diffuse parenchymal lung disease (DPLD), endstage lung disease, lung cancer, pneumonia and acute lung injury, and pulmonary hypertension.